共 50 条
- [5] Osimertinib improves progression-free survival in NSCLC [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (04): : 251 - 251
- [7] Osimertinib improves progression-free survival in NSCLC [J]. LANCET ONCOLOGY, 2018, 19 (01): : E10 - E10
- [9] Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma [J]. Bone Marrow Transplantation, 2008, 42 : 529 - 534
- [10] Rituximab maintenance therapy after autologous stem cell transplantation prolongs progression-free survival in patients with mantle cell lymphoma [J]. Leukemia, 2014, 28 : 708 - 709